Jones Christy
SEC Form 4 insider trading activity
Jones Christy has filed 5 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2026. 5 of those filings fall inside the rolling window. Most recent filing: Sep 23, 2026.
On the most recent filing, Jones Christy is listed as Director at Beta Bionics, Inc. Inside the rolling window, Jones Christy reported no open-market purchases and 4 open-market sales totaling $228K in BBNX. The largest disclosed transaction in the window is a sale of 6,430 BBNX shares on Sep 22, 2026, worth $148K.
Companies traded
Other insiders at BBNX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$228K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Jones Christy made?
Jones Christy has filed 5 SEC Form 4 filings (6 transaction rows) across 1 company since 2026.
Which companies does Jones Christy trade?
Jones Christy has filed SEC Form 4 disclosures for 1 company, including BBNX.
When was Jones Christy's most recent SEC Form 4 filing?
Jones Christy's most recent SEC Form 4 filing on Tracefour is dated Sep 23, 2026.
What is Jones Christy's total buy and sell value in the current window?
Inside the rolling retention window, Jones Christy bought $0 and sold $228K based on SEC Form 4 filings.
What was Jones Christy's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 6,430 BBNX shares on 2026-09-22, worth $148K, per SEC Form 4 filings.